DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Maxim Group Maintains Buy on BeiGene, Lowers Price Target to $190

Maxim Group maintains BeiGene (NASDAQ:BGNE) with a Buy and lowers the price target from $210 to $190.

Benzinga · 03/03/2020 16:17

Maxim Group maintains BeiGene (NASDAQ:BGNE) with a Buy and lowers the price target from $210 to $190.